000 | 01506 a2200445 4500 | ||
---|---|---|---|
005 | 20250516071632.0 | ||
264 | 0 | _c20120221 | |
008 | 201202s 0 0 eng d | ||
022 | _a1555-9823 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRostambeigi, Nassir | |
245 | 0 | 0 |
_aWhen is the best time to initiate peri-operative heparin therapy in general surgery patients? A risk-benefit dilemma. _h[electronic resource] |
260 |
_bThe American surgeon _cNov 2011 |
||
300 |
_a1539-45 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study | ||
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeparin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMinnesota _xepidemiology |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
650 | 0 | 4 |
_aPreoperative Care _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurgical Procedures, Operative |
650 | 0 | 4 |
_aThromboembolism _xepidemiology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGreenlee, Susan M | |
700 | 1 | _aHuebner, Marianne | |
700 | 1 | _aFarley, David R | |
773 | 0 |
_tThe American surgeon _gvol. 77 _gno. 11 _gp. 1539-45 |
|
999 |
_c21417074 _d21417074 |